retatrutide gip glp-1 glucagon receptor agonist Retatrutide: How the Triple Compares to Tirzepatide Use of an unapproved triple-hormone

They share the same three primary receptor targets: GLP-1 GIP Glucagon Because of this shared mechanism, both compounds are part of the broader movement toward multi-agonist incretin drugs designed to influence several metabolic hormone systems simultaneously

When used for overweight or obesity, the drugs are typically prescribed in higher doses than when prescribed for diabetes

If the liquid looks cloudy, discolored, or contains visible particles, do not use it

Four specific GLP-1 medications were examined: semaglutide (Wegovy, Ozempic, Rybelsus), liraglutide (Saxenda), exenatide (Byetta, Bydureon BCise), and dulaglutide (Trulicity)

It is also undergoing research for solo administration and in other combinations

It provides enough material for approximately one week of maintenance-dose administration (assuming 12mg target, with a reconstitution concentration that allows accurate measurement)